Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines

Phase 1 and 2 clinical trials of group B streptococcal (GBS) capsular polysaccharide (CPS)-protein conjugate vaccines in healthy adults have demonstrated their safety and improved immunogenicity compared with uncoupled CPSs. Two recent trials sought to determine (i) whether adsorption of conjugate v...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Paoletti, L. C., Rench, M. A., Kasper, D. L., Molrine, D., Ambrosino, D., Baker, C. J.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 2001
Konular:	Microbial Immunity and Vaccines
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC100045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11598040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.11.6696-6701.2001
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines

Benzer Materyaller